secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2026-09-25T20:30:25+00:00
Accession:  0001213900-26-103530
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08, 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Rocket One sets Dec 17, 2026 annual meeting; shareholder proposals due Oct 1
----------------------------------------------------------------------------

- Board set the 2026 annual meeting for December 17, 2026, more than 25 days after the one-year anniversary of the 2025 meeting held August 5, 2025.
- Bylaw advance-notice nominations or business must reach the Secretary at 720 Monroe Street, Suite E514, Hoboken, NJ 07030 by close of business October 5, 2026.
- Rule 14a-8 proposals for inclusion in the 2026 proxy statement are due by close of business October 1, 2026.
- Universal proxy notices under Rule 14a-19 must be received by October 19, 2026, in addition to Bylaw advance-notice requirements.
- CEO Robb Knie signed the report dated September 25, 2026; no other corporate actions or financial terms were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390026103530/0001213900-26-103530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390026103530/ea0306677-8k_rocket.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-103530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer